ArticleFrontiers in physiology2025
Kefir enhances stress resilience and mitigates PTSD-related behavioral and hematological changes in mice.
Article in Frontiers in physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Amifostine alleviates ionizing radiation-induced small intestinal motility dysfunction in mice by remodeling the structure of the enteric nervous system.Histochemistry and cell biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Post-traumatic stress disorder (PTSD) is a complex psychiatric condition characterized by behavioral, cognitive, immunological, and neurochemical disturbances following traumatic experiences. Despite various therapeutic approaches, effective long-term treatments remain limited, highlighting the need for preventive strategies that enhance stress resilience. In this study, we evaluated the impact of long-term kefir consumption on behavioral, hematological, and biochemical parameters in a mouse model displaying some PTSD-like features, particularly fear- and anxiety-related behaviors induced by acute inescapable stress. Male C57BL/6J mice received kefir daily for 2 months before stress induction via electric foot shocks and continued supplementation for five additional months during recovery. Behavioral testing demonstrated that kefir-fed mice exhibited reduced anxiety-like behaviors, including increased exploration in the open field, elevated plus maze, and light/dark box tests. These mice also showed fewer freezing episodes in the aversive context test, indicating attenuated fear memory. Hematological analysis revealed a modest reduction in erythrocyte count and monocytes, alongside elevated paraoxonase (PON) activity, suggesting enhanced antioxidant defense and a shift toward anti-inflammatory immune responses. RT-qPCR analysis of the cerebral cortex showed increased steady-state transcript levels of genes involved in oxidative stress response and neuroprotection (TXNRD1, UGDH, HSPB8, GADD45B, PPARGC1A) and decreased levels of the pro-inflammatory cytokine gene IL6 transcript. These results indicate that long-term kefir intake mitigates stress-induced behavioral and physiological alterations, likely through modulation of immune and oxidative stress pathways. Taken together, our findings support the potential of kefir as a functional dietary intervention for promoting stress resilience and alleviating PTSD-like symptoms, possibly via mechanisms involving the gut-brain axis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.